Netzer, William J <br/><br/>
Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  02 2017 
 - 1389-1394 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1620963114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--genetics<br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Amyloid beta-Peptides--metabolism<br/>Amyloid beta-Protein Precursor--metabolism<br/>Animals<br/>Aspartic Acid Endopeptidases--antagonists & inhibitors<br/>Brain--drug effects<br/>Cell Line, Tumor<br/>Humans<br/>Imatinib Mesylate--pharmacology<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Peptide Fragments--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Proteolysis--drug effects